We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Start-Ups To Once Again Play Starring Role at MEDICA 2024

By LabMedica International staff writers
Posted on 07 Nov 2024

The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62 countries from Armenia to China and America to Rwanda. More...

They will be exhibiting their innovative solutions on the MEDICA INNOVATION FORUM stage as part of MEDICA (Düsseldorf, Germany), the leading international trade fair for the healthcare and medical equipment industries to be held in Düsseldorf from 11 to 14 November 2024.

At the MEDICA INNOVATION FORUM alone, more than 120 luminaries – including global players such as Microsoft, HP, HTC, 3M, Roche, Huawei, and KUKA – will be showcasing and discussing groundbreaking innovations and best practices. Key topics will include generative AI and big data, robotics, XR and digital twins, mobile health and medical wearables, 3D printing, the Internet of Medical Things and solutions for the hospitals of the future. The MEDICA INNOVATION FORUM will also provide a meeting place and networking platform, “Women Leaders in Healthcare.” With this year’s record participation of 60 young businesses, the MEDICA START-UP PARK will be offering visiting professionals the opportunity to familiarize themselves with a host of other exciting health start-ups and their innovations.

This year’s top 12 health techpreneurs will be presenting their solutions in the pitch final at the 16th Healthcare Innovation World Cup. This will take place on stage at the MEDICA INNOVATION FORUM, where speakers will showcase the next generation of smart health devices, medical wearables, XR solutions, digital biomarkers, electroceuticals, and smart bandages. Finalists Saventic Health, U-Care Medical Srl, and IQONIC.AI are all in on artificial intelligence. Saventic uses AI to detect rare diseases, U-Care to improve clinical outcomes in intensive care units, and IQONIC.AI provides AI-supported dermatology solutions for analyzing skin conditions and issuing personalized treatment recommendations based on advanced imaging technology.

The robotics category will be represented in the final by Robota, Robeauté, and Goodbot. Specifically, Robeauté is supporting the medical profession by supplying neurosurgical micro-robots. Robota offers an automated system for sterilizing surgical instruments, while Goodbot provides an innovative pipetting robot. Doctorderma, Vertify GmbH, and PharmaTrail AG will present their health apps. PharmaTrail develops digital solutions to streamline and optimize clinical trial management to improve efficiency and data accuracy in pharmaceutical research. AGED Diagnostics, Fepod Oy Ltd., and Dxcover are focused on laboratory diagnostics. For example, Dxcover will present an innovative liquid biopsy technology for the early detection of cancer via a simple blood test.

At an exciting onstage program, 3D printing will be the subject of discussion, before attention turns to innovative prosthetics, orthotics, and similar applications. The future of therapy will also be the center of attention at the forum. The series of talks will run the gamut from digital tools for home patient care to robot-assisted surgery, rehabilitation, and assistive technologies. The final day at the MEDICA INNOVATION FORUM will include an international flavor, with healthcare hubs from Finland, France, Germany, Taiwan, and Japan presenting their organizations. This will also offer a perfect segue into the MEDICA START-UP PARK near the forum stage. In this space, start-ups from all over the world – including Germany, Italy, India, Japan, Taiwan, Switzerland, and the United States – will be putting their innovations for healthcare on show.

Related Links:
MEDICA


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
New
Automated Immunoassay Analyzer
SuperFlex™
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: MPNST is a cancer of the connective tissue surrounding peripheral nerves, with NF1 being a key risk factor (Image Credit: Nephron/Wikimedia Commons (CC BY-SA 3.0)

Liquid Biopsy Shows Promise for Detecting and Monitoring Malignant Nerve Sheath Tumors

Malignant peripheral nerve sheath tumor (MPNST) is one of the most serious cancers affecting people with neurofibromatosis type 1 (NF1), yet timely recognition remains difficult. Clinicians often struggle... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.